Skip to main content
. 2018 Aug 31;9(68):33030–33042. doi: 10.18632/oncotarget.26050

Figure 5.

Figure 5

(A) In vivo efficacy of flavopiridol and carfilzomib in mice (n=36) with NCI-H295R-Luc xenografts. XIAP (B) and cleaved-caspase 3 (C) expressions by immunohistochemistry in NCI-H295R xenografts treated with flavopiridol, carfilzomib, and vehicle control.